As it was expected, the results showed that FPH obviously alleviated the secondary liver injury of UC mice including alleviating the steatosis and mitigating inflammation of the liver and significantly reduced the levels of ALT and AST in serum and IL-18, NLRP3, LPS, LBP, sCD14, and TNFα in liver tissues. This evidence concerns the gene IL18 and steatosis.